LifeStance Health Group, Inc. SEC filings LFST

LifeStance Health Group, Inc. has 502 filings in SEC EDGAR's recent list, going back to Feb 16, 2021. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

LifeStance Health Group, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Nov 5, 2026 Nov 5, 2026
8-K Current report
Officer or director change
Oct 16, 2026 Oct 14, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 5, 2026 —
4 Insider transaction Sep 24, 2026 Sep 22, 2026
4 Insider transaction Sep 15, 2026 Sep 11, 2026
8-K Current report
Other events
Sep 11, 2026 Sep 9, 2026
424B7 Filing Sep 10, 2026 —
424B7 Filing Sep 9, 2026 —
4 Insider transaction Sep 4, 2026 Sep 2, 2026
4 Insider transaction Sep 4, 2026 Sep 2, 2026
144 Notice of proposed sale Sep 2, 2026 —
4 Insider transaction Aug 26, 2026 Aug 24, 2026
4 Insider transaction Aug 18, 2026 Aug 14, 2026
4 Insider transaction Aug 14, 2026 Aug 13, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
144 Notice of proposed sale Aug 14, 2026 —
4 Insider transaction Aug 13, 2026 Aug 11, 2026
144 Notice of proposed sale Aug 13, 2026 —
4 Insider transaction Aug 12, 2026 Aug 10, 2026
4 Insider transaction Aug 12, 2026 Aug 10, 2026
4 Insider transaction Aug 12, 2026 Aug 10, 2026
144 Notice of proposed sale Aug 11, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 11, 2026 —
144 Notice of proposed sale Aug 10, 2026 —
144 Notice of proposed sale Aug 10, 2026 —
144 Notice of proposed sale Aug 10, 2026 —
144 Notice of proposed sale Aug 10, 2026 —
144 Notice of proposed sale Aug 10, 2026 —
144 Notice of proposed sale Aug 10, 2026 —
144 Notice of proposed sale Aug 10, 2026 —
144 Notice of proposed sale Aug 10, 2026 —
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Aug 6, 2026 Aug 6, 2026
SCHEDULE 13G Ownership over 5% (passive) Jul 29, 2026 —
4 Insider transaction Jul 14, 2026 Jul 6, 2026
4 Insider transaction Jul 7, 2026 Jul 2, 2026
4 Insider transaction Jul 7, 2026 Jul 2, 2026
4 Insider transaction Jul 7, 2026 Jul 2, 2026
4 Insider transaction Jul 7, 2026 Jul 2, 2026
4 Insider transaction Jul 7, 2026 Jul 2, 2026
4 Insider transaction Jul 7, 2026 Jul 2, 2026
3 Initial insider ownership Jul 7, 2026 Jul 2, 2026
3 Initial insider ownership Jul 7, 2026 Jul 2, 2026
3 Initial insider ownership Jul 7, 2026 Jul 2, 2026
8-K Current report
Officer or director change
Jul 7, 2026 Jul 2, 2026
4 Insider transaction Jun 30, 2026 Jun 26, 2026
144 Notice of proposed sale Jun 26, 2026 —
4 Insider transaction Jun 15, 2026 Jun 11, 2026
8-K Current report
Shareholder vote results
Jun 4, 2026 Jun 2, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
4 Insider transaction May 14, 2026 May 12, 2026
4 Insider transaction May 14, 2026 May 12, 2026
4 Insider transaction May 14, 2026 May 12, 2026
4 Insider transaction May 14, 2026 May 12, 2026
8-K Current report
Other events
May 12, 2026 May 7, 2026
4 Insider transaction May 11, 2026 May 7, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 8, 2026 —
424B7 Filing May 8, 2026 —
424B7 Filing May 8, 2026 —
144 Notice of proposed sale May 7, 2026 —
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations, Regulation FD disclosure
May 7, 2026 May 7, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 6, 2026 —
4 Insider transaction Apr 27, 2026 Apr 23, 2026
144 Notice of proposed sale Apr 24, 2026 —
4 Insider transaction Apr 23, 2026 Apr 21, 2026
144 Notice of proposed sale Apr 23, 2026 —
ARS Annual report to shareholders Apr 22, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 22, 2026 —
DEF 14A Proxy statement Apr 22, 2026 Jun 2, 2026
144 Notice of proposed sale Apr 21, 2026 —
4 Insider transaction Apr 3, 2026 Apr 1, 2026
4 Insider transaction Mar 26, 2026 Mar 24, 2026
4 Insider transaction Mar 19, 2026 Mar 17, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
8-K Current report
Officer or director change
Mar 11, 2026 Mar 10, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 6, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
8-K Current report
Other events
Mar 2, 2026 Feb 25, 2026
424B7 Filing Feb 27, 2026 —
424B7 Filing Feb 26, 2026 —
S-8 Employee stock plan registration Feb 25, 2026 —
10-K Annual report Feb 25, 2026 Dec 31, 2025
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure, Other events
Feb 25, 2026 Feb 25, 2026
3 Initial insider ownership Feb 24, 2026 Feb 16, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 5, 2026 —
3/A Filing Jan 29, 2026 Sep 24, 2024
4 Insider transaction Dec 23, 2025 Dec 19, 2025
144 Notice of proposed sale Dec 22, 2025 —
4 Insider transaction Dec 19, 2025 Dec 18, 2025
4 Insider transaction Dec 19, 2025 Dec 17, 2025
144 Notice of proposed sale Dec 19, 2025 —
144 Notice of proposed sale Dec 18, 2025 —
144 Notice of proposed sale Dec 17, 2025 —
4 Insider transaction Dec 16, 2025 Dec 12, 2025
144 Notice of proposed sale Dec 15, 2025 —
144 Notice of proposed sale Dec 12, 2025 —
4 Insider transaction Nov 25, 2025 Nov 21, 2025
144 Notice of proposed sale Nov 21, 2025 —
4 Insider transaction Nov 13, 2025 Nov 10, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 13, 2025 —
4/A Filing Nov 12, 2025 Mar 6, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 7, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Nov 6, 2025 Nov 6, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 5, 2025 —
4 Insider transaction Oct 28, 2025 Aug 20, 2025
3 Initial insider ownership Oct 28, 2025 Aug 20, 2025
4 Insider transaction Aug 27, 2025 Aug 26, 2025
8-K Current report
Officer or director change
Aug 22, 2025 Aug 19, 2025
4 Insider transaction Aug 20, 2025 Aug 18, 2025
4 Insider transaction Aug 20, 2025 Aug 18, 2025
4 Insider transaction Aug 20, 2025 Aug 18, 2025
144 Notice of proposed sale Aug 18, 2025 —
144 Notice of proposed sale Aug 18, 2025 —
144 Notice of proposed sale Aug 18, 2025 —
144 Notice of proposed sale Aug 18, 2025 —
144 Notice of proposed sale Aug 18, 2025 —
144 Notice of proposed sale Aug 18, 2025 —
144 Notice of proposed sale Aug 18, 2025 —
144 Notice of proposed sale Aug 18, 2025 —
4 Insider transaction Aug 12, 2025 Aug 8, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Aug 7, 2025 Aug 7, 2025
4 Insider transaction Jun 18, 2025 Jun 16, 2025
144 Notice of proposed sale Jun 16, 2025 —
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
3 Initial insider ownership Jun 13, 2025 Jun 9, 2025
3 Initial insider ownership Jun 13, 2025 Jun 3, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
8-K Current report
Shareholder vote results
Jun 6, 2025 Jun 3, 2025
144 Notice of proposed sale Jun 5, 2025 —
4 Insider transaction May 19, 2025 Mar 10, 2025
4 Insider transaction May 19, 2025 Mar 10, 2025
4 Insider transaction May 19, 2025 Mar 10, 2025
4 Insider transaction May 19, 2025 Mar 10, 2025
4 Insider transaction May 19, 2025 Mar 10, 2025
4 Insider transaction May 19, 2025 Mar 10, 2025
4 Insider transaction May 19, 2025 Mar 10, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
May 14, 2025 May 14, 2025
10-Q Quarterly report May 7, 2025 Mar 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
May 7, 2025 May 7, 2025
ARS Annual report to shareholders Apr 23, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 23, 2025 —
DEF 14A Proxy statement Apr 23, 2025 Jun 3, 2025
4 Insider transaction Apr 10, 2025 Apr 8, 2025
144 Notice of proposed sale Apr 9, 2025 —
144 Notice of proposed sale Apr 8, 2025 —
4 Insider transaction Apr 3, 2025 Apr 1, 2025
4 Insider transaction Apr 3, 2025 Apr 1, 2025
4 Insider transaction Mar 26, 2025 Mar 24, 2025
4/A Filing Mar 26, 2025 Mar 17, 2025
4 Insider transaction Mar 18, 2025 Mar 17, 2025
4 Insider transaction Mar 18, 2025 Mar 17, 2025
3 Initial insider ownership Mar 18, 2025 Mar 17, 2025
4/A Filing Mar 17, 2025 Mar 6, 2025
144 Notice of proposed sale Mar 17, 2025 —
4 Insider transaction Mar 12, 2025 Mar 7, 2025
4 Insider transaction Mar 10, 2025 Mar 6, 2025
4 Insider transaction Mar 10, 2025 Mar 6, 2025
4 Insider transaction Mar 10, 2025 Mar 6, 2025
4 Insider transaction Mar 10, 2025 Mar 6, 2025
4 Insider transaction Mar 10, 2025 Mar 6, 2025
4 Insider transaction Mar 10, 2025 Mar 6, 2025
4 Insider transaction Mar 10, 2025 Mar 6, 2025
144 Notice of proposed sale Mar 10, 2025 —
144 Notice of proposed sale Mar 7, 2025 —
S-8 Employee stock plan registration Feb 27, 2025 —
10-K Annual report Feb 27, 2025 Dec 31, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Feb 27, 2025 Feb 25, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Feb 27, 2025 Feb 27, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2025 —
8-K Current report
Material agreement, Agreement ended, New debt
Dec 19, 2024 Dec 19, 2024
4 Insider transaction Dec 2, 2024 Nov 27, 2024
144 Notice of proposed sale Nov 27, 2024 —
4 Insider transaction Nov 15, 2024 Nov 13, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
144 Notice of proposed sale Nov 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 8, 2024 —
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Health Services (SIC 8000)
Listed as
LFST (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Scottsdale, AZ
SEC filer status
Large accelerated filer
SEC CIK
1845257

Other Services-Health Services companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.